Current approaches to the management of diabetic retinopathy

Abstract

This review reflects the current status of the diabetic retinopathy treatment problem and describes the results of the largest trials on epidemiology, screening and the risk factors for complications. In addition, this article describes the current approaches and treatment options for diabetic retinopathy, including a description of fenofibroic acid with its mechanism of action and data from clinical trials. This article also contains information on antiangiogenic agents for intravitreal administration.

Keywords

• diabetic retinopathy
• risk factors
• diabetic macular oedema
• vegf
• fenofibroic acid